A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer Learn More
Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS Learn More
